Greenbrook TMS Inc (GBNHF)

Market Cap	2.90M
Revenue (ttm)	77.37M
Net Income (ttm)	-64.36M
Shares Out	40.80M
EPS (ttm)	-2.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	96,557
Open	0.0850
Previous Close	0.0860
Day's Range	0.0455 - 0.0860
52-Week Range	0.0377 - 0.1680
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About GBNHF

Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared neurostimulation therapy for the treatment of major depressive disorder and other mental health disorders. The company also offers Spravato, an esketamine nasal spray; and other treatment modalities for the treatment of depression and related psychiatric services. Greenbrook TMS Inc. was fo...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2011
• Employees: 508
• Stock Exchange: OTCMKTS
• Ticker Symbol: GBNHF

Financial Performance

In 2022, Greenbrook TMS's revenue was $69.10 million, an increase of 32.39% compared to the previous year's $52.20 million. Losses were -$61.73 million, 149.4% more than in 2021.